
The innovative drug sector surged in the short term, with Chimin hitting the daily limit
The innovative drug sector saw a short-term surge, with Chimin hitting the daily limit, while Nosseland, Lifeon Pharmaceutical, Mabwell, HITECK, and Xintian Pharma all rose significantly

